An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a Phase I clinical trial has shown.

A Los Angeles boy is being credited with saving the life of his father by donating stem cells to help treat his dad’s leukemia. Just nine years old at the time, Stephen Mondek is the youngest person ...

When Los Angeles anesthesiologist Dr. Nick Mondek learned his leukemia had returned earlier this year, he feared his options ...

Seven-year-old Avukile from KwaZulu-Natal triumphed over acute lymphoblastic leukaemia, reaching a significant milestone after a stem cell transplant.

Dr Gail Miflin, chief medical officer at NHSBT, said it could not have carried out its life-saving work "without the millions ...

When someone has a stroke — a leading worldwide cause of death and disability — time is of the essence. Almost nine out of 10 cases are ischemic strokes, caused by restricted blood flow in the brain, ...

Dec 24, 2003 — Double transplantation of autologous stem cells improves overall survival among patients with myeloma, as compared to single transplant, according to results of a randomized trial ...

Mismatched unrelated donor stem-cell transplants achieved 80% survival at 1 year with post-transplant cyclophosphamide (PTCy) prophylaxis for GVHD. PTCy prophylaxis expands donor availability ...

Trachea cancer patient receives new trachea grown from own stem cells. Jan. 13, 2012— -- Christopher Lyles, 30, of Abingdon, Md, exhausted the limited treatment options available in the U.S. for ...